The Feasibility of Florbetapir Quantitation

Completed · Phase 4

Conditions studied: Alzheimers Disease

In brief

The overall objective of the study is to assess the feasibility of implementing a quantitative process of florbetapir F 18 scan interpretation. The hypothesis is that the use of quantitative analysis will increase the accuracy of florbetapir F 18 scan interpretation.

Key facts

Study ID

NCT01946243

Run by

Avid Radiopharmaceuticals

People needed

96

Starts

2013-08-01

Expected to finish

2014-04-01

Last updated by the study team

2015-06-29

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Readers have undergone Amyvid reader training
• Readers have minimal experience with quantitation of amyloid PET scans

You may not qualify if…

• Readers have previously been trained to quantitate amyloid PET scans

Where it is running

• Research Site — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.